Stantec Inc. (NYSE:STN) Stock Rated “Moderate Buy” by Sell-Side Brokerages

Shares of Stantec Inc. (NYSE:STN) (TSE:STN) have earned an average rating of “Moderate Buy” from the seven analysts that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $175.00.

STN has been the topic of a number of research reports. Wall Street Zen downgraded Stantec from a “buy” rating to a “hold” rating in a research note on Saturday, October 17th. Weiss Ratings raised Stantec from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Scotiabank reaffirmed an “outperform” rating on shares of Stantec in a research report on Friday, August 14th. Finally, Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Stantec in a research note on Friday, August 14th.

Institutional Trading of Stantec

Hedge funds have recently bought and sold shares of the stock. Pictet Asset Management Holding SA raised its stake in shares of Stantec by 19.0% in the first quarter. Pictet Asset Management Holding SA now owns 3,485,388 shares of the business services provider’s stock worth $300,340,000 after purchasing an additional 557,434 shares during the last quarter. Man Group plc bought a new position in shares of Stantec in the second quarter valued at approximately $121,285,000. Cardinal Capital Management Inc. purchased a new position in shares of Stantec during the third quarter valued at approximately $109,514,000. Bank of America Corp DE purchased a new position in shares of Stantec during the second quarter valued at approximately $104,075,000. Finally, The Manufacturers Life Insurance Company bought a new stake in Stantec during the second quarter worth $98,396,000. 63.86% of the stock is owned by institutional investors.

Stantec Price Performance

Shares of NYSE STN opened at $72.30 on Monday. The company has a market capitalization of $8.11 billion, a price-to-earnings ratio of 17.46 and a beta of 1.01. The business has a 50-day moving average of $70.39 and a 200-day moving average of $79.70. Stantec has a 1-year low of $65.35 and a 1-year high of $111.80. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.50 and a quick ratio of 1.50.

Stantec (NYSE:STN) (TSE:STN) last announced its quarterly earnings data on Wednesday, August 12th. The business services provider reported $1.16 earnings per share for the quarter, topping the consensus estimate of $1.15 by $0.01. The company had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.26 billion. Stantec had a net margin of 5.91% and a return on equity of 19.70%. Stantec has set its FY 2026 guidance at 4.370-4.490 EPS. On average, equities analysts anticipate that Stantec will post 4.42 EPS for the current fiscal year.

Stantec Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Tuesday, September 29th were issued a dividend of C$0.24 per share. This represents a $0.98 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Tuesday, September 29th. Stantec’s dividend payout ratio is 22.12%.

Stantec Company Profile

Stantec Inc is a global professional services company that provides design, engineering, architecture, environmental, and project management services. Its work supports infrastructure and development projects in areas including buildings, transportation, water, energy, and environmental services.

The company serves public- and private-sector clients across North America and in selected international markets. Its multidisciplinary teams help clients plan, design, manage, and deliver projects ranging from transportation networks and water systems to community developments, industrial facilities, and buildings.

Stantec was founded in 1954 in Edmonton, Alberta, by Dr.